The publications on this site are part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Attention Strategic Transactions Users:

Coming Spring 2020! A Better Commercial Strategy Solution. Learn More!

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

CureVac AG / See Company Profile

Alliance / CureVac and Genmab develop mRNA-based antibody therapies / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 24, 2019

Alliance / CureVac, Yale team up in pulmonary diseases / Strategic Transactions / Deal Date: Aug. 1, 2019 / Publish Date: Aug. 22, 2019

Alliance / CureVac, Schepens Eye Inst. team up in ophthalmology / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 20, 2019

Asklepios BioPharmaceutical Inc. / See Company Profile

Alliance / AskBio licenses Selecta’s ImmTOR platform to develop AAV gene therapies for Pompe disease / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Jan. 3, 2020

Financing / Asklepios raises $235mm in first round; TPG and Vida take minority stakes / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 24, 2019

Alliance / Bamboo acquires potential Canavan disease gene therapy from Rowan University / Strategic Transactions / Deal Date: Jul. 1, 2015 / Publish Date: Sep. 20, 2016

Fulcrum Therapeutics Inc. / See Company Profile

Alliance / Acceleron, Fulcrum collaborate in the pulmonary disease space / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Jan. 3, 2020

Alliance / Fulcrum gets global rights to GSK's losmapimod for muscular dystrophy / Strategic Transactions / Deal Date: Apr. 1, 2019 / Update Date: Aug. 1, 2019

Financing / Fulcrum nets $67mm through IPO / Strategic Transactions / Deal Date: Jul. 1, 2019 / Publish Date: Jul. 19, 2019


Medical Devices

Email Alert | RSS Feed

TMRW Life Sciences Inc. / See Company Profile

Financing / TMRW brings in $25mm Series B round in hopes of launching ivfOS IVF platform early next year / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 20, 2019

Financing / IVF cryo-management technology start-up TMRW raises $12mm Series A round / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: Jun. 11, 2019

Impulse Dynamics / See Company Profile

Financing / Series D brings in $80.25mm for Impulse Dynamics / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 5, 2019

Financing / Impulse Dynamics brings in $30mm in financing / Strategic Transactions / Deal Date: May 1, 2016 / Publish Date: May 15, 2017

Financing / Impulse Dynamics closes $45mm round / Strategic Transactions / Deal Date: May 1, 2017 / Publish Date: May 12, 2017

Orchestra BioMed Inc. / See Company Profile

Financing / Orchestra BioMed enters $20mm loan facility with SVB / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 17, 2019

Financing / Orchestra BioMed gets $34mm via Series B-1 financing / Strategic Transactions / Deal Date: Jul. 1, 2019 / Publish Date: Jul. 11, 2019

Alliance / Terumo gets exclusive rights to Orchestra BioMed's Virtue SEB / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 13, 2019


In Vitro Diagnostics

Email Alert | RSS Feed

NanoString Technologies Inc. / See Company Profile

Alliance / Veracyte gets rights to NanoString's diagnostics / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 12, 2019

Financing / NanoString nets $54mm through public offering / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 22, 2019

Financing / NanoString nets $56.7mm though public stock sale / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jun. 22, 2017

Veracyte Inc. / See Company Profile

Alliance / Veracyte gets rights to NanoString's diagnostics / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 12, 2019

Financing / Public offering nets $138mm for Veracyte / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 7, 2019

Alliance / J&J, Veracyte ally in lung cancer diagnostics / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 15, 2019


Pharmaceuticals

Email Alert | RSS Feed

Bavarian Nordic AS / See Company Profile

Financing / Bavarian Nordic sells PRV for $95mm / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 19, 2019

Alliance / GSK divests two travel vaccines to Bavarian Nordic / Strategic Transactions / Deal Date: Oct. 1, 2019 / Update Date: Dec. 1, 2019

Alliance / Janssen's Crucell Holland gets license to Ebola vaccine candidate from Bavarian Nordic / Strategic Transactions / Deal Date: Oct. 1, 2014 / Update Date: Nov. 1, 2019

Sarepta Therapeutics Inc. / See Company Profile

Alliance / Roche gets ex-US rights to Sarepta’s DMD gene therapy SRP9001 / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Jan. 4, 2020

Acquisition / Sarepta pays $165mm to exercise option to acquire Myonexus / Strategic Transactions / Deal Date: Feb. 1, 2019 / Publish Date: Jan. 4, 2020

Alliance / Sarepta, Stride co-develop AAV gene therapies for up to eight CNS/neuromuscular targets / Strategic Transactions / Deal Date: Nov. 1, 2019 / Publish Date: Nov. 19, 2019

Theravance Biopharma Inc. / See Company Profile

Alliance / Pfizer gets global rights to Theravance JAK inhibitors / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 27, 2019

Alliance / Mylan gets rights to Theravance Biopharma's Phase II COPD candidate / Strategic Transactions / Deal Date: Feb. 1, 2015 / Update Date: Jun. 1, 2019

Financing / Theravance secures $250mm via private financing of notes / Strategic Transactions / Deal Date: Dec. 1, 2018 / Publish Date: Dec. 6, 2018

Biotechnology

Biotechnology

Email Alert | RSS Feed

CureVac AG / See Company Profile

Alliance / CureVac and Genmab develop mRNA-based antibody therapies / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 24, 2019

Alliance / CureVac, Yale team up in pulmonary diseases / Strategic Transactions / Deal Date: Aug. 1, 2019 / Publish Date: Aug. 22, 2019

Alliance / CureVac, Schepens Eye Inst. team up in ophthalmology / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 20, 2019

Asklepios BioPharmaceutical Inc. / See Company Profile

Alliance / AskBio licenses Selecta’s ImmTOR platform to develop AAV gene therapies for Pompe disease / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Jan. 3, 2020

Financing / Asklepios raises $235mm in first round; TPG and Vida take minority stakes / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 24, 2019

Alliance / Bamboo acquires potential Canavan disease gene therapy from Rowan University / Strategic Transactions / Deal Date: Jul. 1, 2015 / Publish Date: Sep. 20, 2016

Fulcrum Therapeutics Inc. / See Company Profile

Alliance / Acceleron, Fulcrum collaborate in the pulmonary disease space / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Jan. 3, 2020

Alliance / Fulcrum gets global rights to GSK's losmapimod for muscular dystrophy / Strategic Transactions / Deal Date: Apr. 1, 2019 / Update Date: Aug. 1, 2019

Financing / Fulcrum nets $67mm through IPO / Strategic Transactions / Deal Date: Jul. 1, 2019 / Publish Date: Jul. 19, 2019

Medical
Devices

Medical Devices

Email Alert | RSS Feed

TMRW Life Sciences Inc. / See Company Profile

Financing / TMRW brings in $25mm Series B round in hopes of launching ivfOS IVF platform early next year / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 20, 2019

Financing / IVF cryo-management technology start-up TMRW raises $12mm Series A round / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: Jun. 11, 2019

Impulse Dynamics / See Company Profile

Financing / Series D brings in $80.25mm for Impulse Dynamics / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 5, 2019

Financing / Impulse Dynamics brings in $30mm in financing / Strategic Transactions / Deal Date: May 1, 2016 / Publish Date: May 15, 2017

Financing / Impulse Dynamics closes $45mm round / Strategic Transactions / Deal Date: May 1, 2017 / Publish Date: May 12, 2017

Orchestra BioMed Inc. / See Company Profile

Financing / Orchestra BioMed enters $20mm loan facility with SVB / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 17, 2019

Financing / Orchestra BioMed gets $34mm via Series B-1 financing / Strategic Transactions / Deal Date: Jul. 1, 2019 / Publish Date: Jul. 11, 2019

Alliance / Terumo gets exclusive rights to Orchestra BioMed's Virtue SEB / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 13, 2019

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

NanoString Technologies Inc. / See Company Profile

Alliance / Veracyte gets rights to NanoString's diagnostics / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 12, 2019

Financing / NanoString nets $54mm through public offering / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 22, 2019

Financing / NanoString nets $56.7mm though public stock sale / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jun. 22, 2017

Veracyte Inc. / See Company Profile

Alliance / Veracyte gets rights to NanoString's diagnostics / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 12, 2019

Financing / Public offering nets $138mm for Veracyte / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 7, 2019

Alliance / J&J, Veracyte ally in lung cancer diagnostics / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 15, 2019

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Bavarian Nordic AS / See Company Profile

Financing / Bavarian Nordic sells PRV for $95mm / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 19, 2019

Alliance / GSK divests two travel vaccines to Bavarian Nordic / Strategic Transactions / Deal Date: Oct. 1, 2019 / Update Date: Dec. 1, 2019

Alliance / Janssen's Crucell Holland gets license to Ebola vaccine candidate from Bavarian Nordic / Strategic Transactions / Deal Date: Oct. 1, 2014 / Update Date: Nov. 1, 2019

Sarepta Therapeutics Inc. / See Company Profile

Alliance / Roche gets ex-US rights to Sarepta’s DMD gene therapy SRP9001 / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Jan. 4, 2020

Acquisition / Sarepta pays $165mm to exercise option to acquire Myonexus / Strategic Transactions / Deal Date: Feb. 1, 2019 / Publish Date: Jan. 4, 2020

Alliance / Sarepta, Stride co-develop AAV gene therapies for up to eight CNS/neuromuscular targets / Strategic Transactions / Deal Date: Nov. 1, 2019 / Publish Date: Nov. 19, 2019

Theravance Biopharma Inc. / See Company Profile

Alliance / Pfizer gets global rights to Theravance JAK inhibitors / Strategic Transactions / Deal Date: Dec. 1, 2019 / Publish Date: Dec. 27, 2019

Alliance / Mylan gets rights to Theravance Biopharma's Phase II COPD candidate / Strategic Transactions / Deal Date: Feb. 1, 2015 / Update Date: Jun. 1, 2019

Financing / Theravance secures $250mm via private financing of notes / Strategic Transactions / Deal Date: Dec. 1, 2018 / Publish Date: Dec. 6, 2018

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel